Jeroen van de Pol

123 5 How does the general public balance convenience and cognitive pharmaceutical services Table 3: Results from linear regression regarding preferences and importance for CPS. Preferences Univariate linear regression Multivariate linear regression* Regression coefficient Significance (p-value) Regression coefficient Significance (p-value) Age in years 0.096 < 0.001 0.088 < 0.001 Gender • Male • Female Ref 1.302 Ref 0.018 Ref 1.350 Ref 0.018 Educational level • Low • Middle • High Ref -0.503 -4.577 Ref 0.581 < 0.001 Ref N.a. -3.999 Ref N.a. < 0.001 Ethnicity • Dutch • Migratory background Ref -0.042 Ref 0.965 N.a. N.a. N.a. N.a. Number of chronic diseases** 0.440 0.021 N.a. N.a. Number of medicines in use** 0.646 < 0.001 0.143 0.364 Perceiving the pharmacist as a healthcare provider 1.147 < 0.001 1.025 < 0.001 Importance Univariate linear regression Multivariate linear regression* Regression coefficient Significance (p-value) Regression coefficient Significance (p-value) Age in years 0.002 0.011 0.003 0.030 Gender • Male • Female Ref -0.030 Ref 0.304 Ref N.a. Ref N.a. Educational level • Low • Middle • High Ref -0,096 -0.128 Ref 0.058 0.012 Ref -0.104 -0.139 Ref 0.089 0.026 Ethnicity • Dutch • Migratory background Ref -0.134 Ref 0.009 Ref -0.096 Ref 0.122 Number of chronic diseases** -0.024 0.016 -0.047 < 0.001 Number of medicines in use** -0.016 0.054 N.a. N.a. Patient perceiving the pharmacist as a healthcare provider 0.055 < 0.001 0.055 < 0.001 * Covariates with p-values < 0.1 in the univariate analysis were also added in the multivariate analysis. ** Due to high correlation between the number of chronic diseases and number of medicines in use, only the covariate with lowest p-value in univariate analysis was included in the multivariate analysis.